Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

3D Cardiac Electrophysiological Mapping System on Renal Artery Radiofrequency Ablation System for Hypertension: a Prospective, Multicenter, Randomized Controlled Trial

NCT05590871 is registered in ClinicalTrials.gov with Shanghai Hongdian Medical CO., LTD as lead sponsor.

NCT NCT05590871
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05590871 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
3D Cardiac Electrophysiological Mapping System on Renal Artery Radiofrequency Ablation System for Hypertension: a Prospective, Multicenter, Randomized Controlled Trial
Lead sponsor
Shanghai Hongdian Medical CO., LTD
Phase
Not applicable
Overall status
Recruiting
Start date
March 31, 2023
Completion date
December 31, 2026
Enrollment
180 (estimated)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension